echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > Spironolactone unlikely to be associated with increased cancer risk

    Spironolactone unlikely to be associated with increased cancer risk

    • Last Update: 2022-04-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Amspironolactone is an anabolic steroid routinely used to treat heart failure, hypertension, and edema


    "While the FDA warns that "unnecessary use of this drug should be avoided, our data are encouraging that spironolactone is unlikely to be associated with a meaningful prescription at clinical doses" cancer risk,” said senior author John Barbieri, MD, MBA in Dermatology


    article title

    Association of Spironolactone Use With Risk of Cancer A Systematic Review and Meta-analysis

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.